Literature DB >> 11106557

Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice.

B Zhu1, D G Kuhel, D P Witte, D Y Hui.   

Abstract

The potential cytostatic function of apolipoprotein (apo) E in vivo was explored by measuring neointimal hyperplasia in response to vascular injury in apoE-deficient and apoE-overexpressing transgenic mice. Results showed a significant increase in medial thickness, medial area, and neointimal formation after vascular injury in both apoE knockout and wild-type C57BL/6 mice. Immunochemical analysis with smooth muscle alpha-actin-specific antibodies revealed that the neointima contained proliferating smooth muscle cells. Neointimal area was 3.4-fold greater, and the intima/medial ratio as well as stenotic luminal area was more pronounced in apoE(-/-) mice than those observed in control mice (P < 0.05). The human apoE3 transgenic mice in FVB/N genetic background were then used to verify a direct effect of apoE in protection against neointimal hyperplasia in response to mechanically induced vascular injury. Results showed that neointimal area was reduced threefold to fourfold in mice overexpressing the human apoE3 transgene (P < 0.05). Importantly, suppression of neointimal formation in the apoE transgenic mice also abolished the luminal stenosis observed in their nontransgenic FVB/N counterparts. These results documented a direct role of apoE in modulating vascular response to injury, suggesting that increasing apoE level may be beneficial in protection against restenosis after vascular surgery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106557      PMCID: PMC1885764          DOI: 10.1016/S0002-9440(10)64823-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Intravascular stents, intimal proliferation and restenosis.

Authors:  E C Santoian; S B King
Journal:  J Am Coll Cardiol       Date:  1992-03-15       Impact factor: 24.094

2.  Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: the problem of restenosis.

Authors:  M B Gravanis; G S Roubin
Journal:  Hum Pathol       Date:  1989-05       Impact factor: 3.466

3.  Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury.

Authors:  C L Jackson; E W Raines; R Ross; M A Reidy
Journal:  Arterioscler Thromb       Date:  1993-08

4.  Apolipoproteins E and C-III have opposing roles in the clearance of lipoprotein remnants in transgenic mice.

Authors:  H V de Silva; S J Lauer; R W Mahley; K H Weisgraber; J M Taylor
Journal:  Biochem Soc Trans       Date:  1993-05       Impact factor: 5.407

5.  Strain differences in neointimal hyperplasia in the rat.

Authors:  S Assadnia; J P Rapp; A L Nestor; T Pringle; G J Cerilli; W T Gunning; T H Webb; M Kligman; D C Allison
Journal:  Circ Res       Date:  1999-06-11       Impact factor: 17.367

Review 6.  Restenosis after coronary angioplasty: an overview.

Authors:  R M Califf; D F Fortin; D J Frid; W R Harlan; E M Ohman; J R Bengtson; C L Nelson; J E Tcheng; D B Mark; R S Stack
Journal:  J Am Coll Cardiol       Date:  1991-05       Impact factor: 24.094

7.  Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty.

Authors:  A Jawien; D F Bowen-Pope; V Lindner; S M Schwartz; A W Clowes
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

8.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

Authors:  A S Plump; J D Smith; T Hayek; K Aalto-Setälä; A Walsh; J G Verstuyft; E M Rubin; J L Breslow
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

9.  Apolipoprotein E prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.

Authors:  N Yamada; I Inoue; M Kawamura; K Harada; Y Watanabe; H Shimano; T Gotoda; M Shimada; K Kohzaki; T Tsukada
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

10.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

Authors:  S H Zhang; R L Reddick; J A Piedrahita; N Maeda
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

View more
  23 in total

Review 1.  Apolipoprotein E-induced cell signaling in the vessel wall.

Authors:  David Y Hui
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

2.  Antiretrovirals induce endothelial dysfunction via an oxidant-dependent pathway and promote neointimal hyperplasia.

Authors:  Bo Jiang; Alok R Khandelwal; Lynette K Rogers; Valeria Y Hebert; James J Kleinedler; James H Zavecz; Weibin Shi; A Wayne Orr; Tammy R Dugas
Journal:  Toxicol Sci       Date:  2010-07-09       Impact factor: 4.849

3.  Apolipoprotein E-mediated cell cycle arrest linked to p27 and the Cox2-dependent repression of miR221/222.

Authors:  Devashish Kothapalli; Paola Castagnino; Daniel J Rader; Michael C Phillips; Sissel Lund-Katz; Richard K Assoian
Journal:  Atherosclerosis       Date:  2012-12-19       Impact factor: 5.162

4.  Atherogenesis in the Carotid Artery with and without Interrupted Blood Flow of Two Hyperlipidemic Mouse Strains.

Authors:  Jian Zhao; Chaoji Huangfu; Zhihui Chang; Andrew T Grainger; Zhaoyu Liu; Weibin Shi
Journal:  J Vasc Res       Date:  2019-09-19       Impact factor: 1.934

5.  Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.

Authors:  Victoria Ulrich; Eddy S Konaniah; Wan-Ru Lee; Sadiksha Khadka; Yu-Min Shen; Joachim Herz; Jane E Salmon; David Y Hui; Philip W Shaul; Chieko Mineo
Journal:  J Am Heart Assoc       Date:  2014-10-14       Impact factor: 5.501

6.  A murine model of arterial restenosis: technical aspects of femoral wire injury.

Authors:  Toshio Takayama; Xudong Shi; Bowen Wang; Sarah Franco; Yifan Zhou; Daniel DiRenzo; Alycia Kent; Peter Hartig; Joshua Zent; Lian-Wang Guo
Journal:  J Vis Exp       Date:  2015-03-10       Impact factor: 1.355

7.  Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase.

Authors:  Zachary W Q Moore; David Y Hui
Journal:  J Lipid Res       Date:  2005-08-01       Impact factor: 5.922

Review 8.  Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain.

Authors:  Marcos A Marques; Phillip A Owens; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease.

Authors:  Marcos A Marques; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 10.  Intimal hyperplasia in murine models.

Authors:  David Y Hui
Journal:  Curr Drug Targets       Date:  2008-03       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.